Literature DB >> 7205637

Hypotensive action of synthetic fragments of parathyroid hormone.

P K Pang, M C Yang, T E Tenner, J K Chang, M Shimizu.   

Abstract

Parathyroid hormone (PTH) and its N-terminal 1-34 fragment were shown to be hypotensive in dogs. In this study, synthetic bovine PTH fragments containing the N-terminal amino acids 1-34, 24-34, 24-28 and 25-27 [bPTH-(1-34), bPTH-(24-34), bPTH-(24-28) and bPTH-(24-27)] were synthesized and tested for hypotensive activity in dogs. bPTH-(1-34) is the most potent of these. The tripeptide is ineffective at doses as high as 2 mg/kg. bPTH-(24-34) and bPTH-(24-28) exhibited hypotensive activity but were less effective than bPTH-(1-34). A decrease in chain length decreased the hypotensive activity. The maximum response produced by bPTH-(1-34) was greater than that of either bPTH-(24-34) or bPTH-(24-28). The maximum responses, however, of bPTH-(24-34) and bPTH-(24-28) were similar. Another striking difference between bPTH-(1-34) and the other two effective fragments was the duration of action. Whereas the action of bPTH-(1-34) at ED50 lasted for up to 6 min the action of bPTH-(24-34) and bPTH-(24-28) lasted for less than 1 min. The hypotensive effect of these three bPTH fragments was not affected by propranolol, phentolamine, atropine, promethazine or cimetidine. In the perfused rat hindlimb, bPTH-(24-28) produced log dose-related sustained vasodilation.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7205637

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  3 in total

1.  Specific inhibition of long-lasting, L-type calcium channels by synthetic parathyroid hormone.

Authors:  P K Pang; R Wang; J Shan; E Karpinski; C G Benishin
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

2.  Parathyroid hypertension.

Authors:  A K Sangal; D G Beevers
Journal:  Br Med J (Clin Res Ed)       Date:  1983-02-12

3.  Parathyroid hormone in coronary artery disease--results of a prospective study.

Authors:  G Herrmann; R Hehrmann; H C Scholz; M Atkinson; P Lichtlen; A von zur Mühlen; R D Hesch
Journal:  J Endocrinol Invest       Date:  1986-08       Impact factor: 4.256

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.